Survey Reveals Challenges in Adult Immunization Adoption

Written by Arushi Sharma, Susi

The recent survey focused on shedding light upon the intricate challenges surrounding the adoption of adult immunization. The findings underscored a series of barriers that have impeded the seamless integration of vaccinations into the adult population.

Survey Reveals Challenges in Adult Immunization Adoption
Exploring the landscape of adult immunization adoption through a comprehensive survey, uncover the challenges and barriers hindering widespread acceptance. 

A survey conducted in 16 Indian cities by The Association of Physicians of India and Ipsos indicates barriers to adult immunization acceptance. Adults over the age of 50, carers, and medical professionals were among those who took part, providing insight into low adult vaccination uptake.

Despite 71% adult vaccination knowledge among individuals 50 and older, only 16% received immunizations.

Doctors (90%) attribute poor adoption to a lack of recommendations, time restrictions, patient fees, and treatment preferences. Patients complain about a lack of firm clinician advice.

Respondents (55% adults, 48% caregivers) advocate COVID-19-like awareness methods to increase rates.

In Mumbai, 73% are informed, yet just 11% have been immunized. Doctors must be trusted, since 50% of adults and 20% of caretakers would accept doctor's advice.

Mumbai doctors recommended vaccines to 9% of aging adults; patients consult family. Western doctors worry about receptivity, affordability, and info gaps.

Dr Agam Vora, Secretary of The Association of Physicians of India said

“there is a need for formal guidelines and awareness programs to increase doctor confidence in recommending adult vaccination.”

Addressing misconceptions about adult vaccination is crucial, with 50% fearing dose dependency. India’s low shingles awareness underscores the need to educate adults aged 50+ about preventable disease risks for effective immunization.

The shingles survey highlights low awareness, leading to delayed diagnosis and suboptimal treatment. Chronic conditions like diabetes and hypertension heighten shingles vulnerability, reinforcing vaccination importance.

API, Ipsos, and GSK conducted a survey involving 1,950 adults aged 50+, 409 caregivers, and 345 doctors from Feb to Mar 2023. Additionally, the study examined shingles patients’ awareness and impact, involving 216 patients/caregivers quantitatively and 10 qualitatively between Jan and Mar 2023, covering cities like Delhi and Mumbai.

Share article